Language barrier means millions of elderly can't access Alzheimer's trials

Student voices

By | Josh Eibelman , NPR

in this NPR Op-Ed, Josh Eibelman '20 describes how millions of individuals suffering from Alzheimers that are not fluent in English are barred from participating in clinical trials to treat Alzheimers. 

"According to interviews with doctors, government officials and pharmaceutical companies, few Alzheimer's studies include medical interpreters to help patients complete the specialized neuropsychological testing component required," Eibelman writes. 

Continue reading the full article on the NPR website. 

More News from A&S

Event poster in bright purple, pink and orange hues: Louise Farrence at 150
Provided

Commemorating composer, pianist pedagogue Louise Farrenc Nov. 14-15

Music
A&S Communications
Sky scrapers rise from New York City in an aeriel shot
Triston Dunn/Unsplash New York City

Is Mamdani’s win indicative of a new wave in national politics? Not likely says Cornell expert

Government
A&S Communications
people sitting around a table
Joseph Lubeck '78, right, meets with students and Professor Ross Brann during a recent campus visit, where they spoke about Lubeck's grandfather, Morris Escoll '1916, and an essay he wrote about life as a Jewish student at Cornell. Provided

Alumni gift endows director position for Jewish Studies Program

Jewish Studies Program
A&S Communications
Black and white image of a college student's face next to an image of a hand-written letter
Photo illustration by Ashley Osburn/Cornell University A student chronicled her life in the ’50s and ’60s—then shared those memories with her daughter and granddaughter

How hundreds of letters home connect a Cornellian family

Cornellians
View all news
Students performing clinical research.